Dare Bioscience Inc reports results for the quarter ended in September - Earnings Summary

Dare Bioscience

10/11/2022 14:32

* Dare Bioscience Inc  DARE.OQ  reported a quarterly
adjusted loss
of 8 cents​​ per share for the quarter ended in September. The
mean expectation of five analysts for the quarter was for a loss
of 12 cents per share.
    * Reported revenue was zero​; analysts expected $1.99
million. 
    * Dare Bioscience Inc's reported EPS for the quarter was a
loss
of 8 cents​.
    * The mean earnings estimate of analysts had risen by
about 14.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Dare Bioscience Inc shares had fallen by 6.0% this
quarter and
lost 53.0% so far this year.
    * The company reported a quarterly loss of $7.02 million.
    * Wall Street's median 12-month price target for Dare
Bioscience
Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 02:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.12          -0.08          Beat
 Jun. 30 2022      -0.06          0.00           Beat
 Mar. 31 2022      -0.14          -0.10          Beat
 Dec. 31 2021      -0.15          -0.18          Missed